B-SUPREME Study (Aligos Therapeutics)
The study will assess the potential safety and effectiveness
of an investigational* medicine called ALG-000184 in people with clinical diagnosis of chronic hepatitis B virus (HBV) infection.
To learn more and find out if you are eligible, please contact:
Akiko Mizuta
Telephone Number: (650)721-8711
Email: amizuta@stanford.edu